Trial Profile
Evaluation of the therapeutic efficacy and safety of pyronaridine-artesunate for the treatment of uncomplicated falciparum malaria in areas of artemisinin-resistant falciparum malaria in Viet Nam
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jul 2019
Price :
$35
*
At a glance
- Drugs Artesunate/pyronaridine (Primary)
- Indications Falciparum malaria; Malaria
- Focus Therapeutic Use
- 10 Jul 2019 Actual date last participant enrolled: 12/20/2018
- 10 Jul 2019 Status changed from recruiting to completed.
- 02 Aug 2018 New trial record